Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 836 results for "eli lilly"

Nisa Investment Advisors LLC Boosts Position in Eli Lilly and Co. (LLY)
Zolmax News

BRIEF-Lilly says neoMONARCH phase 2 trial met primary endpoint...

n"Dec 8 Eli Lilly and Co : * Eli Lilly and Co - trial met its primary endpoint of reducing expression of KI67, a biomarker of cell proliferation, after two weeks of treatment * Eli Lilly-results showed abemaciclib monotherapy, abemaciclib in ... Reuters UK, 2 hours ago

416 images for eli lilly

Zolmax News, 1 day ago
American Banking News, 1 day ago
BioSpace, 55 minutes ago
Yahoo! Singapore, 2 hours ago
Inside INdiana Business, 2 days ago
Mideast Time, 2 days ago
CNBC, 5 days ago, 1 week ago, 1 week ago
WKRB News, 1 week ago

Lilly Presents neoMONARCH Phase 2 Data on Abemaciclib in Early-Stage Breast Cancer

Lilly Eli (NYSE:LLY) Intraday Stock Chart SAN ANTONIO, Dec. 8, 2016 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced that the neoMONARCH study of abemaciclib, a cyclin-dependent kinase (CDK) 4 and CDK 6 inhibitor, met its ...
 ADVFN India3 hours ago Lilly Presents NeoMONARCH Phase2 Data On Abemaciclib In EarlyStage Breast Cancer  RTTNews.com2 hours ago Eli Lilly Presents neoMONARCH Phase 2 Data On Abemaciclib In Early-Stage Breast Cancer  BioSpace57 minutes ago Lilly to release updated guidance on December 15  Seeking Alpha6 days ago
Yahoo! Finance

Better Buy: Johnson & Johnson vs. Eli Lilly

More Eli Lilly's Alzheimer's program is a bust. Does the market's overreaction make this Big Pharma stock more attractive than Johnson & Johnson's
 Yahoo! Finance19 hours ago Lilly Threatens Sanofi's Dominance in Insulin With Knockoff Drug  La Repubblica22 hours ago Are DTC ads tipping the balance in psoriasis battle between Lilly's Taltz and Novartis Cosentyx?  FiercePharma3 days ago Lupin in diabetes drug pact  The Telegraph6 days ago

Lilly to lay off sales reps in wake of Alzheimer's failure

When Eli Lilly's much anticipated Alzheimer's prospect solanezumab failed a key trial last month, it also put a set of sales jobs on the chopping block. The Big Pharma had staffed up in anticipation of a solanezumab approval, planning to hit the ...
 FiercePharma21 hours ago November's top stories: Wellcome's clinical trial network, Eli Lilly's Alzheimer disease drug trial  Drug Development Technology1 day ago [$$] Prevention of Alzheimer's is the way forward  Yahoo! Finance3 days ago Lilly fails Alzheimer's test  Money Week6 days ago

Jardiance approved to cut cardiovascular death risk

RIDGEFIELD, Conn., and INDIANAPOLIS — Jardiance tablets, marketed by Boehringer Ingelheim and Eli Lilly and Co., have been approved by the Food and Drug Administration to cut the risk of cardiovascular death in adults with type 2 diabetes and ...
 Chain Drug Review1 day ago New drug indication could net more than $1 billion  Formulary Journal2 days ago FDA Approves Boehringer-Lilly's Jardiance for Adults with Type 2 Diabetes  PharmaceuticalProcessing3 days ago FDA approves another indication for Lilly/Boehringer diabetes treatment  Pharmafile3 days ago

Rapid Microbiological Methods & Alternatives To Colony Forming Units: A Pathway To Implementation?

By Hans-Joachim Anders (Novartis), Fred Ayers (Eli Lilly), Carol Davis (Shire), Brian Fitch (Biogen), Deborah Gessell-Lee (Baxter), Scott Hooper (Merck & Co.), Michelle Luebke (Baxter), Jeanne Mateffy (Amgen), Lisa Yan (Shire), and Jeffrey Weber ...
 Pharmaceutical Online1 day ago
Inside INdiana Business

Lilly Spikes on FDA Jardiance Approval (LLY)

Shares of Eli Lilly & Co (LLY) are spiking after the FDA approved and expanded the label
 Yahoo! Finance5 days ago Lilly Drug Earns Additional FDA Approval  Inside INdiana Business2 days ago Eli Lilly spikes after FDA approves label change for diabetes drug to reduce cardiovascular death  CNBC5 days ago

2 Inexpensive, Innovative Pharma Stocks

Recent setbacks don't dent our conviction that Eli Lilly and Bristol-Myers' innovation is underappreciated by
 Yahoo! Finance3 days ago
Zolmax News

Eli Lilly and (LLY) Investment Analysts Recent Ratings Changes

Several analysts have recently updated their ratings and price targets for Eli Lilly and (NYSE: LLY): 12/5/2016 Eli Lilly and was downgraded by analysts at Zacks Investment Research from a hold rating to a sell rating. According to Zacks, In ...
 Zolmax News1 day ago Traditional Knowledge and Culture Expressions Act 2016  The Star (Kenya)5 days ago Eli Lilly (LLY) Trading Near $66.24 Support Level  PredictWallStreet6 days ago ELI LILLY AND : Studies Conducted at Eli Lilly on Antidiabetic Agents Recently Reported (Addition of 20-kDa PEG to Insulin Lispro Alters Absorption and Decreases...  4 Traders6 days ago
Motley Fool

Why Eli Lilly Shares Lost 8% in November

Image source: . What happened November was a rough month to be an investor in pharma giant Eli Lilly ( NYSE:LLY ) . Shares dropped by more than 8% during the period, erasing more than $6 billion from the company's market cap, according to data ...
 Motley Fool5 days ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Get updated on latest news & your favorite topics right in your inbox!
More     Less